Cancer Committee Meeting May 11, 2015 Cancer Liaison Physician Report Karen Lisa Smith MD MPH.

Slides:

Advertisements

Similar presentations

Breast Cancer Patient Issues in Family Practice: An Interactive Session.

Advertisements

Breast Cancer, A Common Problem in Sri Lanka

Kevin S. Hughes, MD, FACS Co-Director, Avon Comprehensive Breast Evaluation Center Massachusetts General Hospital Associate Professor of Surgery Harvard.

Breast Cancer in Pregnancy

TRAM Educational Conference September 19, 2014 Meritus Medical Center 1.

By: Kaylee McCowen.  any malignant growth or tumor caused by abnormal and uncontrolled cell division.  It may spread to other parts of the body through.

I.1 ii.2 iii.3 iv.4 1+1=. i.1 ii.2 iii.3 iv.4 1+1=

I.1 ii.2 iii.3 iv.4 1+1=. i.1 ii.2 iii.3 iv.4 1+1=

How is place of death for cancer patients changing and what affects it? UKACR Conference September 28 th 2004 Elizabeth Davies Karen Linklater Ruth Jack.

BIOLOGICAL PRINCIPLES OF BREAST CANCER TREAMENT Benjamin O. Anderson, M.D. Director, Breast Health Clinic Professor of Surgery and Global Health, University.

Impact of Cancer Diagnosis and Chemotherapy on Mammography Use Xinhua Yu, M.B., Ph.D. A. Marshall McBean, M.D., M.Sc. Beth A. Virnig, Ph.D., M.P.H Division.

Prognostic factors for breast cancer survival in affluent and deprived areas Jasmina Stefoski-Mikeljevic.

West Midlands Cancer Intelligence Unit NHSBSP Surgical QA Data for the Year of Screening 1 April 2002 to 31 March 2003 Dr Gill Lawrence and Professor Jan.

The All Breast Cancer Report was published in October breastscreen/research.html#breast- cancer-report.

Ductal Carcinoma in situ

Racial/Ethnic Disparities in Cancer Incidence, Survival and Treatment Linda C. Harlan, PhD, MPH National Cancer Institute Division of Cancer Control and.

The influence of Breast Cancer Pay for Performance Initiatives on breast cancer survival and performance measures: a pilot study in Taiwan Raymond NC Kuo,

Driving the Transition to Individualized Cancer Treatment by Addressing Critical Questions 1 Do I need surgery? chemotherapy? radiation? INVASIVE BREAST.

FEMALE BREAST CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/03/20014.

Variations in Cancer Surgery Across the East Midlands and North Trent EMPHIN Forum (Apr 2010) Carolynn Gildea Trent Cancer Registry.

How are we doing? Quality in Breast Cancer Care Dr Michelle Goecke Surgical Oncology Network Update October 18, 2014.

THYROID CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 09/02/2013.

Breast Cancer: The Profile Ma. Belen E. Tamayo,M.D. Medical Oncologist Makati Medical Center The Medical City.

PROSTATE CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 09/01/2013.

Quality Assurance Report TTUHSC Breast Center of Excellence January 1, 2013 – December 31, 2013 Compiled by Uzma Nazim, M.D.

MELANOMA JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/16/20014.

Breast Cancer: Treatment or Not? HFE 742 Cathy Simmons November 10, 2005.

2014 Cancer Program Performance Outcomes. Introduction Saint Agnes Medical Center has proudly maintained a American College of Surgeons’ Commission on.

A Glimpse of the Science Behind the American Cancer Society Access to Care Campaign Impact of Being Uninsured or Underinsured on Individuals with Cancer.

LUNG CANCER Johns Hopkins Hospital Lung Cancer, Non-Small Cell , All Cases n=1364 Analytic - Initially Diagnosed and/or received all.

THYROID CANCER JOHNS HOPKINS HOSPITAL CANCER REGISTRY Prepared by Theresa SanLorenzo-Caswell, CTR 10/16/20014.

Maryland Comprehensive Cancer Control Vinay K. Gupta, MD FACS Maryland State Cancer Liaison Physician June 6, 2014.

Diversity and the Burden of Cancer David C. Momrow, M.P.H. Senior Vice President of Cancer Control American Cancer Society – Eastern Division January 21,

© American College of Surgeons 2015—Content cannot be reproduced or repurposed without written permission of the American College of Surgeons. Lima, St.

Understanding Cancer and Related Topics

Adjuvant Radiation is Not Associated with Improved Survival in Patients with Positive Margins Following Lobectomy for Stage I & II Non-Small Cell Lung.

2015 Cancer Program Performance Outcomes. Introduction Saint Agnes Medical Center has proudly maintained a American College of Surgeons’ Commission on.

GASTRIC CANCER JHH Johns Hopkins Hospital Gastric Cancer , All Cases n=317 Analytic - Initially Diagnosed and/or received all or.

14 th Annual Meeting of the Connective Tissue Oncology Society November 13-15, 2008, London, UK Oliver Zivanovic, Mario M. Leitao, Alexia Iasonos, Lindsay.

S1207: Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients.

NCDB Report on Breast Cancer at Sibley Cancer Committee Feb Cancer Liaison Physician Karen Lisa Smith MD MPH.

Cancer Liaison Physician Report Sibley Memorial Hospital Cancer Committee Meeting September 14, 2015.

Florida Cancer Plan Phil Roland, MD FACS FACOG Florida State Chair A Commission on Cancer.

The Cancer Registry of Norway Jan F Nygård Head of the IT-department.

NAACCR June 2010 The System Performance Initiative: A Pan-Canadian Approach 1.

Quality & Sustainability in Cancer Control: A System Performance Spotlight Report To use a hyperlink, right click on it and select ‘Open Hyperlink’, or.

Presented at the NAACCR Annual Conference Quebec City June 22, 2010.

Johns Hopkins Hospital Cancer Registry Melanoma

JHH Prostate Cancer Prostate Cancer Cases Diagnosed 1999 – 2004 Analytic vs. Non-Analytic n=7776 * Analytic - Initially Diagnosed and/or received.

The Role of the HCC Cancer Registry in Facilitating Cancer Research Linda Cope, CTR HCC Registry Coordinator

Cancer Program Annual Outcomes Report 2016

What does the data tell us? Colorectal CANCER IN NEVADA

Indiana State Cancer Registry

THE IMPORTANCE OF STAGING AND PROGNOSTIC FACTORS IN CANCER CARE

NON-SMALL CELL LUNG CANCER

JOHNS HOPKINS HOSPITAL CANCER REGISTRY

JOHNS HOPKINS CANCER REGISTRY 2009

Differences in Primary Care Clinicians' Approach to Non-small Cell Lung Cancer Patients Compared with Breast Cancer Timothy R. Wassenaar, MD, Jens C.

#BlackHealthMatters: Improving Breast Cancer Outcomes for Black Women

Marcelo Calil Instituto Brasileiro de Controle do Câncer

Cancer Program Annual Outcomes Report 2017

تهیه کننده: استاد مربوطه: بهار 1392

Nirav S. Kapadia, MD, MS, Luca F. Valle, MD, Julie A

A Model to Predict the Use of Surgical Resection for Advanced-Stage Non-Small Cell Lung Cancer Patients Elizabeth A. David, MD, Stina W. Andersen, PhD,

Differences in Primary Care Clinicians' Approach to Non-small Cell Lung Cancer Patients Compared with Breast Cancer Timothy R. Wassenaar, MD, Jens C.

All for One: Multidisciplinary Management in EGFR-Mutated NSCLC

Elizabeth A. David, MD, MAS, Stina W. Andersen, PhD, Laurel A

Increasing Rates of No Treatment in Advanced-Stage Non–Small Cell Lung Cancer Patients: A Propensity-Matched Analysis Elizabeth A. David, MD, Megan E.

Arti Parikh-Patel, PhD MPH Cyllene Morris, DVM MPVM

NSCLC: Staging and TNM classification

Presentation transcript:

Cancer Committee Meeting May 11, 2015 Cancer Liaison Physician Report Karen Lisa Smith MD MPH

5 year survival for breast cancer patients at Sibley

StageEnter0 Year1 Year2 Year3 Year4 Year5 Year5 Year 95% CI Stage Stage I Stage II Stage III Stage IV3Insufficient cases (n<30) Unknown All cases for this data set 1,

5 year survival for breast cancer patients at all sites in the NCDB

StageEnter0 Year1 Year2 Year3 Year4 Year5 Year5 Year 95% CI Stage 0136, Stage I272, Stage II196, Stage III74, Stage IV25, Not Applicabl e Unknown33, All cases for this data set 738,

Breast cancer 5 year survival Sibley outcomes comparable to or better than national NCDB outcomes

Number of new prostate cancer patients at Sibley in comparison to other DC hospitals

Diagnosis Year of Prostate Cancer Diagnosed in 2010,2011,2012 Sibley Memorial Hospital, Washington DC vs. All Types Hospitals in State of District of Columbia All Diagnosed Cases - Data from 7 Hospitals # Diagnosis Year My (N) Oth. (N)My (%)Oth. (%) %39.43% %34.77% %25.8% Col. TOTAL %

Prostate cancer cases at Sibley Numbers are low What can we do to capture more of the regional market?

CP3R Measures for Breast Cancer for Sibley compared to all COC Approved Programs (2012)

MeasureSibleyAll COC approved programs *Breast Conserving Surgery for Stage 0-250%63% Image or palpation guided core biopsy or FNA to establish diagnosis 85%89% *Tamoxifen or 3 rd generation AI within 1 yar of diagnosis for stage 1B-3 Hormone receptor positive breast cancer 3.4%90% *RT within in year after mastectomy if >=4+ nodes 46.2%87% *RT within one year after BCS for patients < 70 68%91% *Combination chemotherapy considered or given within 120 days of diagnosis if < 70 and hormone receptor negative and stage 1B-3 36%92% * = Sibley rate below mean of COC approved programs

Breast CP3R data Sibley scores are low in many areas Likely represents inaccurate data capture and not poor adherence with these standard of care measures How can we improve data capture for these measures?

Note: inadequate numbers to meaningfully review CP3R data from 2012 for other sites with measures (gastric, colon, lung, rectum, cervix)

Questions?